TRANSDERMAL PATCHES FOR SYSTEMIC DRUG DELIVERY

For pharma companies developing systemic therapies, transdermal patch technology offers essential solutions for APIs with poor oral bioavailability or patient compliance issues. From hormone to pain therapies, ARx patches deliver consistent plasma levels and bypass first-pass metabolism to improve patient outcomes and reduce total API requirements.

EXPLORE YOUR OPTIONS

How Can We Help Your Drug Product?

HOW IT WORKS

Advanced adhesive formulations and permeation enhancers deliver APIs steadily into the bloodstream through controlled-release mechanisms.

20+ YEARS OF MANUFACTURING. DEVELOPMENT ON YOUR TIMELINE.

Your regulatory timeline demands a partner who delivers from feasibility to commercial scale without delays. Get in touch to discuss formulation development, stability testing, and manufacturing capacity for your transdermal patch program.

SEE WHAT’S POSSIBLE

SINGLE OR MULTI-LAYER FOR API STABILITY

CUSTOMIZABLE
ABSORPTION TIMES

GENTLE ADHESIVES FOR ALL-DAY WEAR & REMOVAL

Apply the patch to a clean, dry area of skin

Controlled release delivers medication steadily

Customized absorption for consistent drug release

ABOUT ARx

ARx is a transdermal patch development and manufacturing partner working with pharmaceutical companies on systemic drug delivery from feasibility through commercial production.

We offer:

  • Formulation expertise for single and multi-layer patch systems optimized for API stability
  • FDA-registered cGMP facilities built to meet pharmaceutical manufacturing standards
  • Faster development timelines from feasibility to commercial scale, with comprehensive regulatory support
  • Proven track record with 20 years of commercial manufacturing and 9 positive FDA inspections
  • Scalable production capacity aligned with your regulatory timeline